S-adenosyl-L-homocysteine hydrolase and methylation disorders: Yeast as a model system

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 1, 2013, Pages 204-215

  Tehlivets, Oksana ^a   Malanovic, Nermina ^a   Visram, Myriam ^a   Pavkov Keller, Tea ^b   Keller, Walter ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b AUSTRIAN CENTRE OF INDUSTRIAL BIOTECHNOLOGY   (Austria)

Author keywords

AdoHcy; AdoMet; Homocysteine; S adenosyl L homocysteine hydrolase

Indexed keywords

ADENOSINE; ADENOSYLHOMOCYSTEINASE; ADENOSYLHOMOCYSTEINASE INHIBITOR; ANTIVIRUS AGENT; HOMOCYSTEINE; S ADENOSYLMETHIONINE;

ANTIVIRAL ACTIVITY; CATALYSIS; ENZYME DEFECT; ENZYME DEGRADATION; ENZYME LOCALIZATION; ENZYME STRUCTURE; ENZYME SYNTHESIS; GENE SILENCING; HUMAN; HYDROLYSIS; HYPERHOMOCYSTEINEMIA; LIPID METABOLISM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN METHYLATION; REVIEW; YEAST;

ADENOSYLHOMOCYSTEINASE; ANIMALS; HUMANS; METHYLATION; MODELS, BIOLOGICAL; S-ADENOSYLMETHIONINE; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EUKARYOTA;

EID: 84868548868     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.09.007     Document Type: Review

References (160)

1. Luka Z., Mudd S.H., Wagner C. Glycine N-methyltransferase and regulation of S-adenosylmethionine levels. J. Biol. Chem. 2009, 284:22507-22511.
2. Cantoni G.L. Biological methylation: selected aspects. Annu. Rev. Biochem. 1975, 44:435-451.
3. Lu S.C. S-adenosylmethionine. Int. J. Biochem. Cell Biol. 2000, 32:391-395.
4. Fontecave M., Atta M., Mulliez E. S-adenosylmethionine: nothing goes to waste. Trends Biochem. Sci. 2004, 29:243-249.
5. Finkelstein J.D. The metabolism of homocysteine: pathways and regulation. Eur. J. Pediatr. 1998, 157:S40-S44.
6. Elmore C.L., Wu X., Leclerc D., Watson E.D., Bottiglieri T., Krupenko N.I., Krupenko S.A., Cross J.C., Rozen R., Gravel R.A., Matthews R.G. Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase. Mol. Genet. Metab. 2007, 91:85-97.
7. Malanovic N., Streith I., Wolinski H., Rechberger G., Kohlwein S.D., Tehlivets O. S-adenosyl-l-homocysteine hydrolase, key enzyme of methylation metabolism, regulates phosphatidylcholine synthesis and triacylglycerol homeostasis in yeast: implications for homocysteine as a risk factor of atherosclerosis. J. Biol. Chem. 2008, 283:23989-23999.
8. Martinez-Chantar M.L., Corrales F.J., Martinez-Cruz L.A., Garcia-Trevijano E.R., Huang Z.Z., Chen L., Kanel G., Avila M.A., Mato J.M., Lu S.C. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J. 2002, 16:1292-1294.
9. Martinez-Chantar M.L., Vazquez-Chantada M., Ariz U., Martinez N., Varela M., Luka Z., Capdevila A., Rodriguez J., Aransay A.M., Matthiesen R., Yang H., Calvisi D.F., Esteller M., Fraga M., Lu S.C., Wagner C., Mato J.M. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 2008, 47:1191-1199.
10. Chen Z., Karaplis A.C., Ackerman S.L., Pogribny I.P., Melnyk S., Lussier-Cacan S., Chen M.F., Pai A., John S.W., Smith R.S., Bottiglieri T., Bagley P., Selhub J., Rudnicki M.A., James S.J., Rozen R. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 2001, 10:433-443.
11. Teng Y.W., Mehedint M.G., Garrow T.A., Zeisel S.H. Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas. J. Biol. Chem. 2011, 286:36258-36267.
12. Namekata K., Enokido Y., Ishii I., Nagai Y., Harada T., Kimura H. Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. J. Biol. Chem. 2004, 279:52961-52969.
13. Cano A., Buque X., Martinez-Una M., Aurrekoetxea I., Menor A., Garcia-Rodriguez J.L., Lu S.C., Martinez-Chantar M.L., Mato J.M., Ochoa B., Aspichueta P. Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice. Hepatology 2011, 54:1975-1986.
14. Baric I. Inherited disorders in the conversion of methionine to homocysteine. J. Inherit. Metab. Dis. 2009, 32:459-471.
15. Chamberlin M.E., Ubagai T., Mudd S.H., Wilson W.G., Leonard J.V., Chou J.Y. Demyelination of the brain is associated with methionine adenosyltransferase I/III deficiency. J. Clin. Invest. 1996, 98:1021-1027.
16. Mita T., Kawazu I., Hirano H., Ohmori O., Janjua N., Shibata K. E1 mice epilepsy shows genetic polymorphism for S-adenosyl-l-homocysteine hydrolase. Neurochem. Int. 2001, 38:349-357.
17. Petrossian T.C., Clarke S.G. Uncovering the human methyltransferasome. Mol. Cell. Proteomics 2011, 10. (M110 000976).
18. Petrossian T., Clarke S. Bioinformatic identification of novel methyltransferases. Epigenomics 2009, 1:163-175.
19. Grillo M.A., Colombatto S. S-adenosylmethionine and protein methylation. Amino acids 2005, 28:357-362.
20. Lee D.Y., Teyssier C., Strahl B.D., Stallcup M.R. Role of protein methylation in regulation of transcription. Endocr. Rev. 2005, 26:147-170.
21. Polevoda B., Sherman F. Methylation of proteins involved in translation. Mol. Microbiol. 2007, 65:590-606.
22. Lee Y.H., Stallcup M.R. Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation. Mol. Endocrinol. 2009, 23:425-433.
23. Dillon S.C., Zhang X., Trievel R.C., Cheng X. The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol. 2005, 6:227.
24. Malik S., Bhaumik S.R. Mixed lineage leukemia: histone H3 lysine 4 methyltransferases from yeast to human. FEBS J. 2011, 277:1805-1821.
25. Chern M.K., Chang K.N., Liu L.F., Tam T.C., Liu Y.C., Liang Y.L., Tam M.F. Yeast ribosomal protein L12 is a substrate of protein-arginine methyltransferase 2. J. Biol. Chem. 2002, 277:15345-15353.
26. Wong C.M., Tang H.M., Kong K.Y., Wong G.W., Qiu H., Jin D.Y., Hinnebusch A.G. Yeast arginine methyltransferase Hmt1p regulates transcription elongation and termination by methylating Npl3p. Nucleic Acids Res. 2010, 38:2217-2228.
27. Yu M.C., Bachand F., McBride A.E., Komili S., Casolari J.M., Silver P.A. Arginine methyltransferase affects interactions and recruitment of mRNA processing and export factors. Genes Dev. 2004, 18:2024-2035.
28. Liu Q., Dreyfuss G. In vivo and in vitro arginine methylation of RNA-binding proteins. Mol. Cell. Biol. 1995, 15:2800-2808.
29. Tolstykh T., Lee J., Vafai S., Stock J.B. Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits. EMBO J. 2000, 19:5682-5691.
30. Hrycyna C.A., Clarke S. Modification of eukaryotic signaling proteins by C-terminal methylation reactions. Pharmacol. Ther. 1993, 59:281-300.
31. Chow C.S., Lamichhane T.N., Mahto S.K. Expanding the nucleotide repertoire of the ribosome with post-transcriptional modifications. ACS Chem. Biol. 2007, 2:610-619.
32. Hou Y.M., Perona J.J. Stereochemical mechanisms of tRNA methyltransferases. FEBS Lett. 2011, 584:278-286.
33. Mao X., Schwer B., Shuman S. Mutational analysis of the Saccharomyces cerevisiae ABD1 gene: cap methyltransferase activity is essential for cell growth. Mol. Cell. Biol. 1996, 16:475-480.
34. Tsukamoto T., Shibagaki Y., Niikura Y., Mizumoto K. Cloning and characterization of three human cDNAs encoding mRNA (guanine-7-)-methyltransferase, an mRNA cap methylase. Biochem. Biophys. Res. Commun. 1998, 251:27-34.
35. Noga A.A., Stead L.M., Zhao Y., Brosnan M.E., Brosnan J.T., Vance D.E. Plasma homocysteine is regulated by phospholipid methylation. J. Biol. Chem. 2003, 278:5952-5955.
36. Stead L.M., Brosnan J.T., Brosnan M.E., Vance D.E., Jacobs R.L. Is it time to reevaluate methyl balance in humans?. Am. J. Clin. Nutr. 2006, 83:5-10.
37. Clarke S., Banfield K. S-adenosylmethionine-dependent methyltransferases. Homocysteine in Health and Disease 2001, 63-78. Cambridge University Press. R. Carmel, D.W. Jackobsen (Eds.).
38. Bacolla A., Pradhan S., Roberts R.J., Wells R.D. Recombinant human DNA (cytosine-5) methyltransferase. II. Steady-state kinetics reveal allosteric activation by methylated DNA. J. Biol. Chem. 1999, 274:33011-33019.
39. Mao X., Schwer B., Shuman S. Yeast mRNA cap methyltransferase is a 50-kilodalton protein encoded by an essential gene. Mol. Cell. Biol. 1995, 15:4167-4174.
40. Hausmann S., Zheng S., Fabrega C., Schneller S.W., Lima C.D., Shuman S. Encephalitozoon cuniculi mRNA cap (guanine N-7) methyltransferase: methyl acceptor specificity, inhibition BY S-adenosylmethionine analogs, and structure-guided mutational analysis. J. Biol. Chem. 2005, 280:20404-20412.
41. Shugart L., Chastain B. Escherichia coli tRNA (uracil-5-)-methyltransferase: inhibition by analogues of adenosylhomocysteine. Enzyme 1979, 24:353-357.
42. Baron R.A., Casey P.J. Analysis of the kinetic mechanism of recombinant human isoprenylcysteine carboxylmethyltransferase (Icmt). BMC Biochem. 2004, 5:19.
43. Johnson B.A., Aswad D.W. Kinetic properties of bovine brain protein l-isoaspartyl methyltransferase determined using a synthetic isoaspartyl peptide substrate. Neurochem. Res. 1993, 18:87-94.
44. Hoffman D.R., Haning J.A., Cornatzer W.E. Microsomal phosphatidylethanolamine methyltransferase: inhibition by S-adenosylhomocysteine. Lipids 1981, 16:561-567.
45. Gaynor P.M., Carman G.M. Phosphatidylethanolamine methyltransferase and phospholipid methyltransferase activities from Saccharomyces cerevisiae. Enzymological and kinetic properties. Biochim. Biophys. Acta 1990, 1045:156-163.
46. Castro R., Rivera I., Martins C., Struys E.A., Jansen E.E., Clode N., Graca L.M., Blom H.J., Jakobs C., de Almeida I.T. Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC. J. Mol. Med. 2005, 83:831-836.
47. Schanche J.S., Schanche T., Ueland P.M. Inhibition of phospholipid methylation in isolated rat hepatocytes by analogues of adenosine and S-adenosylhomocysteine. Biochim. Biophys. Acta 1982, 721:399-407.
48. Huang Y., Komoto J., Konishi K., Takata Y., Ogawa H., Gomi T., Fujioka M., Takusagawa F. Mechanisms for auto-inhibition and forced product release in glycine N-methyltransferase: crystal structures of wild-type, mutant R175K and S-adenosylhomocysteine-bound R175K enzymes. J. Mol. Biol. 2000, 298:149-162.
49. Caudill M.A., Wang J.C., Melnyk S., Pogribny I.P., Jernigan S., Collins M.D., Santos-Guzman J., Swendseid M.E., Cogger E.A., James S.J. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J. Nutr. 2001, 131:2811-2818.
50. Kramer D.L., Porter C.W., Borchardt R.T., Sufrin J.R. Combined modulation of S-adenosylmethionine biosynthesis and S-adenosylhomocysteine metabolism enhances inhibition of nucleic acid methylation and L1210 cell growth. Cancer Res. 1990, 50:3838-3842.
51. Radomski N., Kaufmann C., Dreyer C. Nuclear accumulation of S-adenosylhomocysteine hydrolase in transcriptionally active cells during development of Xenopus laevis. Mol. Biol. Cell 1999, 10:4283-4298.
52. Bjursell M.K., Blom H.J., Cayuela J.A., Engvall M.L., Lesko N., Balasubramaniam S., Brandberg G., Halldin M., Falkenberg M., Jakobs C., Smith D., Struys E., von Dobeln U., Gustafsson C.M., Lundeberg J., Wedell A. Adenosine kinase deficiency disrupts the methionine cycle and causes hypermethioninemia, encephalopathy, and abnormal liver function. Am. J. Hum. Genet. 2011, 89:507-515.
53. Dayal S., Bottiglieri T., Arning E., Maeda N., Malinow M.R., Sigmund C.D., Heistad D.D., Faraci F.M., Lentz S.R. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ. Res. 2001, 88:1203-1209.
54. Loehrer F.M., Tschopl M., Angst C.P., Litynski P., Jager K., Fowler B., Haefeli W.E. Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease. Atherosclerosis 2001, 154:147-154.
55. Herrmann W., Schorr H., Obeid R., Makowski J., Fowler B., Kuhlmann M.K. Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes. Clin. Chem. 2005, 51:891-897.
56. Jabs K., Koury M.J., Dupont W.D., Wagner C. Relationship between plasma S-adenosylhomocysteine concentration and glomerular filtration rate in children. Metabolism 2006, 55:252-257.
57. Poirier L.A., Brown A.T., Fink L.M., Wise C.K., Randolph C.J., Delongchamp R.R., Fonseca V.A. Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy. Metabolism 2001, 50:1014-1018.
58. Leal J., Ferrer I., Blanco-Aparicio C., Hernandez-Losa J., Ramon Y.C., Carnero A., Lleonart M. S-adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis. Carcinogenesis 2008, 29:2089-2095.
59. Miller M.W., Duhl D.M., Winkes B.M., Arredondo-Vega F., Saxon P.J., Wolff G.L., Epstein C.J., Hershfield M.S., Barsh G.S. The mouse lethal nonagouti (a(x)) mutation deletes the S-adenosylhomocysteine hydrolase (Ahcy) gene. EMBO J. 1994, 13:1806-1816.
60. Rocha P.S., Sheikh M., Melchiorre R., Fagard M., Boutet S., Loach R., Moffatt B., Wagner C., Vaucheret H., Furner I. The Arabidopsis HOMOLOGY-DEPENDENT GENE SILENCING1 gene codes for an S-adenosyl-l-homocysteine hydrolase required for DNA methylation-dependent gene silencing. Plant Cell 2005, 17:404-417.
61. Baric I., Fumic K., Glenn B., Cuk M., Schulze A., Finkelstein J.D., James S.J., Mejaski-Bosnjak V., Pazanin L., Pogribny I.P., Rados M., Sarnavka V., Scukanec-Spoljar M., Allen R.H., Stabler S., Uzelac L., Vugrek O., Wagner C., Zeisel S., Mudd S.H. S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:4234-4239.
62. Baric I., Cuk M., Fumic K., Vugrek O., Allen R.H., Glenn B., Maradin M., Pazanin L., Pogribny I., Rados M., Sarnavka V., Schulze A., Stabler S., Wagner C., Zeisel S.H., Mudd S.H. S-adenosylhomocysteine hydrolase deficiency: a second patient, the younger brother of the index patient, and outcomes during therapy. J. Inherit. Metab. Dis. 2005, 28:885-902.
63. Buist N.R., Glenn B., Vugrek O., Wagner C., Stabler S., Allen R.H., Pogribny I., Schulze A., Zeisel S.H., Baric I., Mudd S.H. S-adenosylhomocysteine hydrolase deficiency in a 26-year-old man. J. Inherit. Metab. Dis. 2006, 29:538-545.
64. Grubbs R., Vugrek O., Deisch J., Wagner C., Stabler S., Allen R., Baric I., Rados M., Mudd S.H. S-adenosylhomocysteine hydrolase deficiency: two siblings with fetal hydrops and fatal outcomes. J. Inherit. Metab. Dis. 2010, 33:705-713.
65. Mushegian A.R., Garey J.R., Martin J., Liu L.X. Large-scale taxonomic profiling of eukaryotic model organisms: a comparison of orthologous proteins encoded by the human, fly, nematode, and yeast genomes. Genome Res. 1998, 8:590-598.
66. Stepkowski T., Brzezinski K., Legocki A.B., Jaskolski M., Bena G. Bayesian phylogenetic analysis reveals two-domain topology of S-adenosylhomocysteine hydrolase protein sequences. Mol. Phylogenet. Evol. 2005, 34:15-28.
67. Rao S.T., Rossmann M.G. Comparison of super-secondary structures in proteins. J. Mol. Biol. 1973, 76:241-256.
68. Turner M.A., Yuan C.S., Borchardt R.T., Hershfield M.S., Smith G.D., Howell P.L. Structure determination of selenomethionyl S-adenosylhomocysteine hydrolase using data at a single wavelength. Nat. Struct. Biol. 1998, 5:369-376.
69. Yang X., Hu Y., Yin D.H., Turner M.A., Wang M., Borchardt R.T., Howell P.L., Kuczera K., Schowen R.L. Catalytic strategy of S-adenosyl-l-homocysteine hydrolase: transition-state stabilization and the avoidance of abortive reactions. Biochemistry 2003, 42:1900-1909.
70. Lee K.M., Choi W.J., Lee Y., Lee H.J., Zhao L.X., Lee H.W., Park J.G., Kim H.O., Hwang K.Y., Heo Y.S., Choi S., Jeong L.S. X-ray crystal structure and binding mode analysis of human S-adenosylhomocysteine hydrolase complexed with novel mechanism-based inhibitors, haloneplanocin A analogues. J. Med. Chem. 2011, 54:930-938.
71. Hu Y., Komoto J., Huang Y., Gomi T., Ogawa H., Takata Y., Fujioka M., Takusagawa F. Crystal structure of S-adenosylhomocysteine hydrolase from rat liver. Biochemistry 1999, 38:8323-8333.
72. Takata Y., Yamada T., Huang Y., Komoto J., Gomi T., Ogawa H., Fujioka M., Takusagawa F. Catalytic mechanism of S-adenosylhomocysteine hydrolase. Site-directed mutagenesis of Asp-130, Lys-185, Asp-189, and Asn-190. J. Biol. Chem. 2002, 277:22670-22676.
73. Huang Y., Komoto J., Takata Y., Powell D.R., Gomi T., Ogawa H., Fujioka M., Takusagawa F. Inhibition of S-adenosylhomocysteine hydrolase by acyclic sugar adenosine analogue d-eritadenine. Crystal structure of S-adenosylhomocysteine hydrolase complexed with d-eritadenine. J. Biol. Chem. 2002, 277:7477-7482.
74. Yamada T., Komoto J., Lou K., Ueki A., Hua D.H., Sugiyama K., Takata Y., Ogawa H., Takusagawa F. Structure and function of eritadenine and its 3-deaza analogues: potent inhibitors of S-adenosylhomocysteine hydrolase and hypocholesterolemic agents. Biochem. Pharmacol. 2007, 73:981-989.
75. Yamada T., Takata Y., Komoto J., Gomi T., Ogawa H., Fujioka M., Takusagawa F. Catalytic mechanism of S-adenosylhomocysteine hydrolase: roles of His 54, Asp130, Glu155, Lys185, and Aspl89. Int. J. Biochem. Cell Biol. 2005, 37:2417-2435.
76. Komoto J., Huang Y., Gomi T., Ogawa H., Takata Y., Fujioka M., Takusagawa F. Effects of site-directed mutagenesis on structure and function of recombinant rat liver S-adenosylhomocysteine hydrolase. Crystal structure of D244E mutant enzyme. J. Biol. Chem. 2000, 275:32147-32156.
77. Tanaka N., Nakanishi M., Kusakabe Y., Shiraiwa K., Yabe S., Ito Y., Kitade Y., Nakamura K.T. Crystal structure of S-adenosyl-l-homocysteine hydrolase from the human malaria parasite Plasmodium falciparum. J. Mol. Biol. 2004, 343:1007-1017.
78. Reddy M.C., Kuppan G., Shetty N.D., Owen J.L., Ioerger T.R., Sacchettini J.C. Crystal structures of Mycobacterium tuberculosis S-adenosyl-l-homocysteine hydrolase in ternary complex with substrate and inhibitors. Protein Sci. 2008, 17:2134-2144.
79. Brzezinski K., Dauter Z., Jaskolski M. High-resolution structures of complexes of plant S-adenosyl-l-homocysteine hydrolase (Lupinus luteus). Acta Crystallogr. D 2012, 68:218-231.
80. Brzezinski K., Bujacz G., Jaskolski M. Purification, crystallization and preliminary crystallographic studies of plant S-adenosyl-l-homocysteine hydrolase (Lupinus luteus). Acta Crystallogr. F 2008, 64:671-673.
81. Guranowski A., Pawelkiewicz J. Adenosylhomocysteinase from yellow lupin seeds. Purification and properties. Eur. J. Biochem. 1977, 80:517-523.
82. De La Haba G., Cantoni G.L. The enzymatic synthesis of S-adenosyl-l-homocysteine from adenosine and homocysteine. J. Biol. Chem. 1959, 234:603-608.
83. Hoffman D.R., Marion D.W., Cornatzer W.E., Duerre J.A. S-adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of l-methionine, l-homocystein, and adenosine. J. Biol. Chem. 1980, 255:10822-10827.
84. Palmer J.L., Abeles R.H. The mechanism of action of S-adenosylhomocysteinase. J. Biol. Chem. 1979, 254:1217-1226.
85. Wang M., Borchardt R.T., Schowen R.L., Kuczera K. Domain motions and the open-to-closed conformational transition of an enzyme: a normal mode analysis of S-adenosyl-l-homocysteine hydrolase. Biochemistry 2005, 44:7228-7239.
86. Wang M., Unruh J.R., Johnson C.K., Kuczera K., Schowen R.L., Borchardt R.T. Effects of ligand binding and oxidation on hinge-bending motions in S-adenosyl-l-homocysteine hydrolase. Biochemistry 2006, 45:7778-7786.
87. Hu C., Fang J., Borchardt R.T., Schowen R.L., Kuczera K. Molecular dynamics simulations of domain motions of substrate-free S-adenosyl-l-homocysteine hydrolase in solution. Proteins 2008, 71:131-143.
88. Kloor D., Ludtke A., Stoeva S., Osswald H. Adenosine binding sites at S-adenosylhomocysteine hydrolase are controlled by the NAD+/NADH ratio of the enzyme. Biochem. Pharmacol. 2003, 66:2117-2123.
89. Bethin K.E., Cimato T.R., Ettinger M.J. Copper binding to mouse liver S-adenosylhomocysteine hydrolase and the effects of copper on its levels. J. Biol. Chem. 1995, 270:20703-20711.
90. Bethin K.E., Petrovic N., Ettinger M.J. Identification of a major hepatic copper binding protein as S-adenosylhomocysteine hydrolase. J. Biol. Chem. 1995, 270:20698-20702.
91. Petrovic N., Comi A., Ettinger M.J. Copper incorporation into superoxide dismutase in Menkes lymphoblasts. J. Biol. Chem. 1996, 271:28335-28340.
92. Li M., Li Y., Chen J., Wei W., Pan X., Liu J., Liu Q., Leu W., Zhang L., Yang X., Lu J., Wang K. Copper ions inhibit S-adenosylhomocysteine hydrolase by causing dissociation of NAD+ cofactor. Biochemistry 2007, 46:11451-11458.
93. Huh W.K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W., Weissman J.S., O'Shea E.K. Global analysis of protein localization in budding yeast. Nature 2003, 425:686-691.
94. Radomski N., Barreto G., Kaufmann C., Yokoska J., Mizumoto K., Dreyer C. Interaction of S-adenosylhomocysteine hydrolase of Xenopus laevis with mRNA(guanine-7-)methyltransferase: implication on its nuclear compartmentalisation and on cap methylation of hnRNA. Biochim. Biophys. Acta 2002, 1590:93-102.
95. Kloor D., Hermes M., Fink K., Schmid H., Klingel K., Mack A., Grenz A., Osswald H. Expression and localization of S-adenosylhomocysteine-hydrolase in the rat kidney following carbon monoxide induced hypoxia. Cell. Physiol. Biochem. 2007, 19:57-66.
96. Lee S., Doxey A.C., McConkey B.J., Moffatt B.A. Nuclear targeting of methyl-recycling enzymes in Arabidopsis thaliana is mediated by specific protein interactions. Mol. Plant 2012, 5:231-248.
97. Finkelstein J.D., Martin J.J. Homocysteine. Int. J. Biochem. Cell Biol. 2000, 32:385-389.
98. Golbahar J., Fathi Z., Tamadon M. Distribution of 5,10-methylenetetrahydrofolate reductase (C667T) polymorphism and its association with red blood cell 5-methyltetrahydrofolate in the healthy Iranians. Clin. Nutr. 2005, 24:83-87.
99. Jacobsen D.W. Homocysteine and vitamins in cardiovascular disease. Clin. Chem. 1998, 44:1833-1843.
100. McCully K.S. Homocysteine, vitamins, and vascular disease prevention. Am. J. Clin. Nutr. 2007, 86:1563S-1568S.
101. Refsum H., Ueland P.M., Nygard O., Vollset S.E. Homocysteine and cardiovascular disease. Annu. Rev. Med. 1998, 49:31-62.
102. Bostom A.G., Rosenberg I.H., Silbershatz H., Jacques P.F., Selhub J., D'Agostino R.B., Wilson P.W., Wolf P.A. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann. Intern. Med. 1999, 131:352-355.
103. Wald D.S., Law M., Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002, 325:1202.
104. Williams K.T., Schalinske K.L. Homocysteine metabolism and its relation to health and disease. Biofactors 2010, 36:19-24.
105. Lawrence de Koning A.B., Werstuck G.H., Zhou J., Austin R.C. Hyperhomocysteinemia and its role in the development of atherosclerosis. Clin. Biochem. 2003, 36:431-441.
106. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 2002, 346:476-483.
107. Mattson M.P., Shea T.B. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 2003, 26:137-146.
108. Kim Y.I. Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr. Rev. 1999, 57:314-321.
109. Herrmann W., Quast S., Ullrich M., Schultze H., Bodis M., Geisel J. Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation. Atherosclerosis 1999, 144:91-101.
110. Glushchenko A.V., Jacobsen D.W. Molecular targeting of proteins by l-homocysteine: mechanistic implications for vascular disease. Antioxid. Redox Signal. 2007, 9:1883-1898.
111. Ueland P.M., Refsum H., Beresford S.A., Vollset S.E. The controversy over homocysteine and cardiovascular risk. Am. J. Clin. Nutr. 2000, 72:324-332.
112. Jacobsen D.W. Hyperhomocysteinemia and oxidative stress: time for a reality check?. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1182-1184.
113. Outinen P.A., Sood S.K., Liaw P.C., Sarge K.D., Maeda N., Hirsh J., Ribau J., Podor T.J., Weitz J.I., Austin R.C. Characterization of the stress-inducing effects of homocysteine. Biochem. J. 1998, 332:213-221.
114. Loscalzo J. Homocysteine trials-clear outcomes for complex reasons. N. Engl. J. Med. 2006, 354:1629-1632.
115. Isa Y., Mishima T., Tsuge H., Hayakawa T. Increase in S-adenosylhomocysteine content and its effect on the S-adenosylhomocysteine hydrolase activity under transient high plasma homocysteine levels in rats. J. Nutr. Sci. Vitaminol. 2006, 52:479-482.
116. Kerins D.M., Koury M.J., Capdevila A., Rana S., Wagner C. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am. J. Clin. Nutr. 2001, 74:723-729.
117. Jamaluddin M.S., Yang X., Wang H. Hyperhomocysteinemia, DNA methylation and vascular disease. Clin. Chem. Lab. Med. 2007, 45:1660-1666.
118. James S.J., Melnyk S., Pogribna M., Pogribny I.P., Caudill M.A. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr. 2002, 132:2361S-2366S.
119. Ingrosso D., Perna A.F. Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Biochim. Biophys. Acta 2009, 1790:892-899.
120. Liu C., Wang Q., Guo H., Xia M., Yuan Q., Hu Y., Zhu H., Hou M., Ma J., Tang Z., Ling W. Plasma S-adenosylhomocysteine is a better biomarker of atherosclerosis than homocysteine in apolipoprotein E-deficient mice fed high dietary methionine. J. Nutr. 2008, 138:311-315.
121. Green T.J., Skeaff C.M., McMahon J.A., Venn B.J., Williams S.M., Devlin A.M., Innis S.M. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations. Br. J. Nutr. 2010, 103:1629-1634.
122. Christopher S.A., Melnyk S., James S.J., Kruger W.D. S-adenosylhomocysteine, but not homocysteine, is toxic to yeast lacking cystathionine beta-synthase. Mol. Genet. Metab. 2002, 75:335-343.
123. De Clercq E. John Montgomery's legacy: carbocyclic adenosine analogues as SAH hydrolase inhibitors with broad-spectrum antiviral activity. Nucleos. Nucleot. Nucl. 2005, 24:1395-1415.
124. Huggins J., Zhang Z.X., Bray M. Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model. J. Infect. Dis. 1999, 179:S240-S247.
125. Wolfe M.S., Borchardt R.T. S-adenosyl-l-homocysteine hydrolase as a target for antiviral chemotherapy. J. Med. Chem. 1991, 34:1521-1530.
126. Shuto S., Minakawa N., Niizuma S., Kim H.S., Wataya Y., Matsuda A. New neplanocin analogues. 12. Alternative synthesis and antimalarial effect of (6'R)-6'-C-methylneplanocin A, a potent AdoHcy hydrolase inhibitor. J. Med. Chem. 2002, 45:748-751.
127. Wolos J.A., Frondorf K.A., Davis G.F., Jarvi E.T., McCarthy J.R., Bowlin T.L. Selective inhibition of T cell activation by an inhibitor of S-adenosyl-l-homocysteine hydrolase. J. Immunol. 1993, 150:3264-3273.
128. Chiang P.K. Biological effects of inhibitors of S-adenosylhomocysteine hydrolase. Pharmacol. Ther. 1998, 77:115-134.
129. Masuta C., Tanaka H., Uehara K., Kuwata S., Koiwai A., Noma M. Broad resistance to plant viruses in transgenic plants conferred by antisense inhibition of a host gene essential in S-adenosylmethionine-dependent transmethylation reactions. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:6117-6121.
130. Zanetti G., Pahuja K.B., Studer S., Shim S., Schekman R. COPII and the regulation of protein sorting in mammals. Nat. Cell Biol. 2011, 14:20-28.
131. Nuttall J.M., Motley A., Hettema E.H. Peroxisome biogenesis: recent advances. Curr. Opin. Cell Biol. 2011, 23:421-426.
132. Barros M.H., da Cunha F.M., Oliveira G.A., Tahara E.B., Kowaltowski A.J. Yeast as a model to study mitochondrial mechanisms in ageing. Mech. Ageing Dev. 2010, 131:494-502.
133. Alberghina L., Mavelli G., Drovandi G., Palumbo P., Pessina S., Tripodi F., Coccetti P., Vanoni M. Cell growth and cell cycle in Saccharomyces cerevisiae: basic regulatory design and protein-protein interaction network. Biotechnol. Adv. 2012, 30:52-72.
134. Tehlivets O., Hasslacher M., Kohlwein S.D. S-adenosyl-l-homocysteine hydrolase in yeast: key enzyme of methylation metabolism and coordinated regulation with phospholipid synthesis. FEBS Lett. 2004, 577:501-506.
135. Kohlwein S.D. Obese and anorexic yeasts: experimental models to understand the metabolic syndrome and lipotoxicity. Biochim. Biophys. Acta 2010, 1801:222-229.
136. Reitz R.C., Mead D.J., Bjur R.A., Greenhouse A.H., Welch W.H. Phosphatidylethanolamine N-methyltransferase in human red blood cell membrane preparations. Kinetic mechanism. J. Biol. Chem. 1989, 264:8097-8106.
137. Reitz R.C., Mead D.J., Welch W.H. Phospholipid methylation in brain membrane preparations: kinetic mechanism. Biochim. Biophys. Acta 1993, 1166:139-144.
138. Li Z., Agellon L.B., Allen T.M., Umeda M., Jewell L., Mason A., Vance D.E. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 2006, 3:321-331.
139. Noga A.A., Zhao Y., Vance D.E. An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins. J. Biol. Chem. 2002, 277:42358-42365.
140. Choumenkovitch S.F., Selhub J., Bagley P.J., Maeda N., Nadeau M.R., Smith D.E., Choi S.W. In the cystathionine beta-synthase knockout mouse, elevations in total plasma homocysteine increase tissue S-adenosylhomocysteine, but responses of S-adenosylmethionine and DNA methylation are tissue specific. J. Nutr. 2002, 132:2157-2160.
141. Schwahn B.C., Chen Z., Laryea M.D., Wendel U., Lussier-Cacan S., Genest J., Mar M.H., Zeisel S.H., Castro C., Garrow T., Rozen R. Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB J. 2003, 17:512-514.
142. Werstuck G.H., Lentz S.R., Dayal S., Hossain G.S., Sood S.K., Shi Y.Y., Zhou J., Maeda N., Krisans S.K., Malinow M.R., Austin R.C. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 2001, 107:1263-1273.
143. Hamelet J., Demuth K., Paul J.L., Delabar J.M., Janel N. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice. J. Hepatol. 2007, 46:151-159.
144. Kammoun H.L., Chabanon H., Hainault I., Luquet S., Magnan C., Koike T., Ferre P., Foufelle F. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 2009, 119:1201-1215.
145. Borradaile N.M., Han X., Harp J.D., Gale S.E., Ory D.S., Schaffer J.E. Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J. Lipid Res. 2006, 47:2726-2737.
146. Pineau L., Colas J., Dupont S., Beney L., Fleurat-Lessard P., Berjeaud J.M., Berges T., Ferreira T. Lipid-induced ER stress: synergistic effects of sterols and saturated fatty acids. Traffic 2009, 10:673-690.
147. Ariyama H., Kono N., Matsuda S., Inoue T., Arai H. Decrease in membrane phospholipid unsaturation induces unfolded protein response. J. Biol. Chem. 2010, 285:22027-22035.
148. Peter A., Weigert C., Staiger H., Machicao F., Schick F., Machann J., Stefan N., Thamer C., Haring H.U., Schleicher E. Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 2009, 58:1757-1765.
149. Green C.D., Olson L.K. Modulation of palmitate-induced endoplasmic reticulum stress and apoptosis in pancreatic {beta}-cells by stearoyl-CoA desaturase and Elovl6. Am. J. Physiol. 2011, 300:E640-E649.
150. Busch A.K., Gurisik E., Cordery D.V., Sudlow M., Denyer G.S., Laybutt D.R., Hughes W.E., Biden T.J. Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic beta-cells from lipoapoptosis. Diabetes 2005, 54:2917-2924.
151. Boumann H.A., Chin P.T., Heck A.J., De Kruijff B., De Kroon A.I. The yeast phospholipid N-methyltransferases catalyzing the synthesis of phosphatidylcholine preferentially convert di-C16:1 substrates both in vivo and in vitro. J. Biol. Chem. 2004, 279:40314-40319.
152. Tacconi M., Wurtman R.J. Phosphatidylcholine produced in rat synaptosomes by N-methylation is enriched in polyunsaturated fatty acids. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:4828-4831.
153. DeLong C.J., Shen Y.J., Thomas M.J., Cui Z. Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway. J. Biol. Chem. 1999, 274:29683-29688.
154. Jacobs R.L., Zhao Y., Koonen D.P., Sletten T., Su B., Lingrell S., Cao G., Peake D.A., Kuo M.S., Proctor S.D., Kennedy B.P., Dyck J.R., Vance D.E. Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity. J. Biol. Chem. 2010, 285:22403-22413.
155. Watkins S.M., Zhu X., Zeisel S.H. Phosphatidylethanolamine-N-methyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice. J. Nutr. 2003, 133:3386-3391.
156. Selley M.L. A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease. Neurobiol. Aging 2007, 28:1834-1839.
157. Li D., Mann N.J., Sinclair A.J. A significant inverse relationship between concentrations of plasma homocysteine and phospholipid docosahexaenoic acid in healthy male subjects. Lipids 2006, 41:85-89.
158. Innis S.M., Davidson A.G., Chen A., Dyer R., Melnyk S., James S.J. Increased plasma homocysteine and S-adenosylhomocysteine and decreased methionine is associated with altered phosphatidylcholine and phosphatidylethanolamine in cystic fibrosis. J. Pediatr. 2003, 143:351-356.
159. Tehlivets O. Homocysteine as a risk factor for atherosclerosis: is its conversion to S-adenosyl-l-homocysteine the key to deregulated lipid metabolism?. J. Lipid 2011, 2011. (702853).
160. Landau M., Mayrose I., Rosenberg Y., Glaser F., Martz E., Pupko T., Ben-Tal N. ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res. 2005, 33:W299-W302.